1. A new FGFR inhibitor disrupts the TGF‐β1‐induced fibrotic process
   Mi‐Hyoung Kim et al, 2020, Journal of Cellular and Molecular Medicine CrossRef
2. Multi-functional dual-layer nanofibrous membrane for prevention of postoperative pancreatic leakage
   Prayas Chakma Shanto et al, 2024, Biomaterials CrossRef
3. Breast cancer stem cells: A review of their characteristics and the agents that affect them
   Naing L. Shan et al, 2021, Molecular Carcinogenesis CrossRef
4. Druggable Molecular Targets for the Treatment of Triple Negative Breast Cancer
   Maryam Nakhjavani et al, 2019, Journal of Breast Cancer CrossRef
5. Therapeutic Implications of TGFβ in Cancer Treatment: A Systematic Review
   Verónica Gómez-Gil, 2021, Cancers CrossRef
6. Design, synthesis and biological evaluation of 4-bromo-N-(3,5-dimethoxyphenyl)benzamide derivatives as novel FGFR1 inhibitors for treatment of non-small cell lung cancer
   Zixin Xie et al, 2018, Journal of Enzyme Inhibition and Medicinal Chemistry CrossRef
7. Signaling Pathways and Natural Compounds in Triple-Negative Breast Cancer Cell Line
   Citra Dewi et al, 2022, Molecules CrossRef
8. Potential role of targeted therapies in the treatment of triple-negative breast cancer
   Lee Yueh Jia et al, 2016, Anti-Cancer Drugs CrossRef
9. miR‑497 inhibits the proliferation and migration of A549 non‑small‑cell lung cancer cells by targeting FGFR1
   Qibin Huang et al, 2019, Molecular Medicine Reports CrossRef
10. Research on Mechanism of FGFR1 Inhibitor BAY1163877 against Proliferation of Breast Cancer Cells
    Yingnan Cui et al, 2019, IOP Conference Series: Materials Science and Engineering CrossRef
11. Thalidomide and Its Analogs Differentially Target Fibroblast Growth Factor Receptors: Thalidomide Suppresses FGFR Gene Expression while Pomalidomide Dampens FGFR2 Activity
    Lakshmikirupa Sundaresan et al, 2019, Chemical Research in Toxicology CrossRef
12. Potential therapeutic targets of the JAK2/STAT3 signaling pathway in triple-negative breast cancer
    Lin Long et al, 2024, Frontiers in Oncology CrossRef
13. Radiosensitizing Effect of Novel Phenylpyrimidine Derivatives on Human Lung Cancer Cells via Cell Cycle Perturbation
    Seung-Youn Jung et al, 2019, Journal of Pharmacology and Experimental Therapeutics CrossRef